Danaher Corporation (NYSE:DHR) was the recipient of a large growth in short interest in the month of July. As of July 31st, there was short interest totalling 3,889,234 shares, a growth of 39.5% from the July 14th total of 2,788,130 shares. Based on an average trading volume of 3,946,005 shares, the short-interest ratio is presently 1.0 days. Currently, 0.6% of the company’s shares are sold short.

Shares of Danaher Corporation (NYSE DHR) opened at 80.56 on Wednesday. The company has a market capitalization of $55.96 billion, a PE ratio of 25.71 and a beta of 1.03. The firm’s 50-day moving average is $82.61 and its 200 day moving average is $84.26. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.01.

Danaher Corporation (NYSE:DHR) last posted its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.97 by $0.02. The business had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period last year, the company posted $0.90 earnings per share. Equities research analysts predict that Danaher Corporation will post $3.95 EPS for the current year.

In other news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the business’s stock in a transaction on Monday, July 31st. The shares were sold at an average price of $81.78, for a total value of $799,154.16. Following the completion of the transaction, the insider now owns 155,520 shares of the company’s stock, valued at approximately $12,718,425.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Angela S. Lalor sold 10,815 shares of the business’s stock in a transaction on Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total transaction of $910,190.40. Following the completion of the transaction, the senior vice president now directly owns 39,020 shares of the company’s stock, valued at approximately $3,283,923.20. The disclosure for this sale can be found here. Insiders have sold a total of 38,623 shares of company stock valued at $3,206,426 in the last ninety days. Company insiders own 12.20% of the company’s stock.

A number of large investors have recently bought and sold shares of the company. Palisade Capital Management LLC NJ boosted its stake in Danaher Corporation by 4.0% in the first quarter. Palisade Capital Management LLC NJ now owns 186,675 shares of the conglomerate’s stock worth $15,966,000 after buying an additional 7,118 shares during the last quarter. Lodestar Investment Counsel LLC IL boosted its stake in Danaher Corporation by 1.2% in the first quarter. Lodestar Investment Counsel LLC IL now owns 118,949 shares of the conglomerate’s stock worth $10,174,000 after buying an additional 1,436 shares during the last quarter. Farmers & Merchants Investments Inc. boosted its stake in Danaher Corporation by 6.2% in the first quarter. Farmers & Merchants Investments Inc. now owns 68,985 shares of the conglomerate’s stock worth $5,900,000 after buying an additional 4,000 shares during the last quarter. Howland Capital Management LLC boosted its stake in Danaher Corporation by 0.4% in the first quarter. Howland Capital Management LLC now owns 247,448 shares of the conglomerate’s stock worth $21,164,000 after buying an additional 932 shares during the last quarter. Finally, First United Bank Trust boosted its stake in Danaher Corporation by 2.9% in the first quarter. First United Bank Trust now owns 25,285 shares of the conglomerate’s stock worth $2,163,000 after buying an additional 715 shares during the last quarter. Institutional investors and hedge funds own 76.12% of the company’s stock.

DHR has been the subject of several research analyst reports. Vetr raised shares of Danaher Corporation from a “buy” rating to a “strong-buy” rating and set a $94.18 price target for the company in a report on Thursday, April 20th. Royal Bank Of Canada reissued a “sector perform” rating and issued a $88.00 price target (down previously from $89.00) on shares of Danaher Corporation in a report on Friday, April 21st. Zacks Investment Research lowered shares of Danaher Corporation from a “buy” rating to a “hold” rating in a report on Friday, April 21st. BTIG Research reissued a “buy” rating and issued a $92.00 price target on shares of Danaher Corporation in a report on Sunday, April 23rd. Finally, Cowen and Company reissued an “outperform” rating and issued a $90.00 price target on shares of Danaher Corporation in a report on Sunday, April 23rd. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. Danaher Corporation currently has a consensus rating of “Buy” and a consensus target price of $91.76.

COPYRIGHT VIOLATION WARNING: “Danaher Corporation (DHR) Short Interest Update” was published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international copyright & trademark laws. The original version of this piece can be read at https://www.americanbankingnews.com/2017/08/16/danaher-corporation-dhr-short-interest-update.html.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.